Cancer incidence among workers with blood lead measurements in two countries

30.09.2019

IOM scientists Will Mueller, Peter Ritchie and Prof Damien McElvenny are amongst the co-authors of a paper entitled "Cancer incidence among workers with blood lead measurements in two countries". published in "Occupational and Environmental Medicine"

Objective Study carcinogenicity of inorganic lead, classified as ‘probably carcinogenic’ to humans by the International Agency for Research on Cancer (brain, lung, kidney and stomach).

Methods We conducted internal and external analyses for cancer incidence in two cohorts of 29 874 lead-exposed workers with past blood lead data (Finland, n=20 752, Great Britain=9122), with 6790 incident cancers. Exposure was maximum measured blood lead.

Results The combined cohort had a median maximum blood lead of 29 μg/dL, a mean first blood lead test of 1977, and was 87% male. Significant (p<0.05) positive trends, using the log of maximum blood lead, were found for brain cancer (malignant), Hodgkin’s lymphoma, lung cancer and rectal cancer, while a significant negative trend was found for melanoma. Borderline significant positive trends (0.05≤p≤0.10) were found for oesophageal cancer, meningioma and combined malignant/benign brain cancer. Categorical analyses reflected these trends. Significant interactions by country were found for lung, brain and oesophageal cancer, with Finland showing strong positive trends, and Great Britain showing modest or no trends. Larynx cancer in Finland also showed a positive trend (p=0.05). External analyses for high exposure workers (maximum blood lead >40 μg/dL) showed a significant excess for lung cancer in both countries combined, and significant excesses in Finland for brain and lung cancer. The Great Britain data were limited by small numbers for some cancers, and limited variation in exposure.

Conclusions We found strong positive incidence trends with increasing blood lead level, for several outcomes in internal analysis. Two of these, lung and brain cancer, were sites of a priori interest.

The full text of the paper is available here.

 

  • IOMworld Posted: yesterday
    New insight for Health & Safety managers – Focus your budget for optimal workplace safety & productivity. Read our… https://t.co/6p8o43Tv1d
  • IOMworld Posted: 2 days ago
    We are delighted that IOM’s Nathan Baker & Damien McElvenny will be speaking at the @SHWLive North conference on 14… https://t.co/L5zFuy0PX2
  • IOMworld Posted: 3 days ago
    Join us the @SHWLive North on 14/15 February at Manchester Central, where our experts will be delighted to answer y… https://t.co/qOauTYRS5g
  • IOMworld Posted: 8 days ago
    Staff at Basildon Hospital have been exposed to up to 29x the legal limit of nitrous oxide. We are encouraging hosp… https://t.co/MecOyP4hgc
  • IOMworld Posted: 9 days ago
    We are delighted that IOM’s Rebecca Canham will be hosting ‘5 changes to your work that science shows will improve… https://t.co/9QbEbif1lh
  • IOMworld Posted: 10 days ago
    We are delighted that IOM’s Nathan Baker will be hosting a seminar on 'Working into the future, why people matter m… https://t.co/OHcB3ShpyP
  • IOMworld Posted: 15 days ago
    IOM are excited to be hosting a collaborative focus group as part of 'Exposome Project for Health & Occupational Re… https://t.co/czvDll28zC
  • IOMworld Posted: one month ago
    From everyone at IOM, we want to wish you the best this festive season. Thank you to all of our clients, collaborat… https://t.co/msu9bzPqxy
  • IOMworld Posted: 2 months ago
    RT @claire_horwell: Nice work by my colleagues at the Institute of Occupational Medicine (@IOMworld) on the respirable crystalline #silica
  • IOMworld Posted: 2 months ago
    Read the independent report on #COVID and Occupational Impacts from the UK Injuries Advisory Council. IOM's John Ch… https://t.co/ibKrBhgyul